1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neurological Biomarkers Consumption 2016-2026

2.1.2 Neurological Biomarkers Consumption CAGR by Region

2.2 Neurological Biomarkers Segment by Type

2.2.1 Proteomics

2.2.2 Genomics

2.2.3 Imaging

2.2.4 Bioinformatics

2.2.5 Others

2.3 Neurological Biomarkers Sales by Type

2.3.1 Global Neurological Biomarkers Sales Market Share by Type (2016-2021)

2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2016-2021)

2.3.3 Global Neurological Biomarkers Sale Price by Type (2016-2021)

2.4 Neurological Biomarkers Segment by Application

2.4.1 Diagnostics

2.4.2 Drug Discovery

2.4.3 Personalized Medicine

2.4.4 Others

2.5 Neurological Biomarkers Sales by Application

2.5.1 Global Neurological Biomarkers Sale Market Share by Application (2016-2021)

2.5.2 Global Neurological Biomarkers Revenue and Market Share by Application (2016-2021)

2.5.3 Global Neurological Biomarkers Sale Price by Application (2016-2021)

3 Global Neurological Biomarkers by Company

3.1 Global Neurological Biomarkers Sales Market Share by Company

3.1.1 Global Neurological Biomarkers Sales by Company (2019-2021)

3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2019-2021)

3.2 Global Neurological Biomarkers Revenue Market Share by Company

3.2.1 Global Neurological Biomarkers Revenue by Company (2019-2021)

3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2019-2021)

3.3 Global Neurological Biomarkers Sale Price by Company

3.4 Global Manufacturers Neurological Biomarkers Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neurological Biomarkers Product Location Distribution

3.4.2 Players Neurological Biomarkers Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Neurological Biomarkers by Region

4.1 Global Neurological Biomarkers by Region

4.1.1 Global Neurological Biomarkers Sales by Region

4.1.2 Global Neurological Biomarkers Revenue by Region

4.2 Americas Neurological Biomarkers Sales Growth

4.3 APAC Neurological Biomarkers Sales Growth

4.4 Europe Neurological Biomarkers Sales Growth

4.5 Middle East & Africa Neurological Biomarkers Sales Growth

5 Americas

5.1 Americas Neurological Biomarkers Sales by Country

5.1.1 Americas Neurological Biomarkers Sales by Country (2016-2021)

5.1.2 Americas Neurological Biomarkers Revenue by Country (2016-2021)

5.2 Americas Neurological Biomarkers Sales by Type

5.3 Americas Neurological Biomarkers Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neurological Biomarkers Sales by Region

6.1.1 APAC Neurological Biomarkers Sales by Region (2016-2021)

6.1.2 APAC Neurological Biomarkers Revenue by Region (2016-2021)

6.2 APAC Neurological Biomarkers Sales by Type

6.3 APAC Neurological Biomarkers Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neurological Biomarkers by Country

7.1.1 Europe Neurological Biomarkers Sales by Country (2016-2021)

7.1.2 Europe Neurological Biomarkers Revenue by Country (2016-2021)

7.2 Europe Neurological Biomarkers Sales by Type

7.3 Europe Neurological Biomarkers Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neurological Biomarkers by Country

8.1.1 Middle East & Africa Neurological Biomarkers Sales by Country (2016-2021)

8.1.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2016-2021)

8.2 Middle East & Africa Neurological Biomarkers Sales by Type

8.3 Middle East & Africa Neurological Biomarkers Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Neurological Biomarkers Distributors

10.3 Neurological Biomarkers Customer

11 Global Neurological Biomarkers Market Forecast

11.1 Global Neurological Biomarkers Forecast by Region

11.1.1 Global Neurological Biomarkers Forecast by Regions (2021-2026)

11.2.2 Global Neurological Biomarkers Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Neurological Biomarkers Forecast by Type

11.7 Global Neurological Biomarkers Forecast by Application

12 Key Players Analysis

12.1 Thermo Fisher Scientific

12.1.1 Thermo Fisher Scientific Thermo Fisher Scientific Company Information

12.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Offered

12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Thermo Fisher Scientific Main Business Overview

12.1.5 Thermo Fisher Scientific Latest Developments

12.2 Merck

12.2.1 Merck Company Information

12.2.2 Merck Neurological Biomarkers Product Offered

12.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Merck Main Business Overview

12.2.5 Merck Latest Developments

12.3 Quest Diagnostics

12.3.1 Quest Diagnostics Company Information

12.3.2 Quest Diagnostics Neurological Biomarkers Product Offered

12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Quest Diagnostics Main Business Overview

12.3.5 Quest Diagnostics Latest Developments

12.4 Abbott

12.4.1 Abbott Company Information

12.4.2 Abbott Neurological Biomarkers Product Offered

12.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Abbott Main Business Overview

12.4.5 Abbott Latest Developments

12.5 Roche

12.5.1 Roche Company Information

12.5.2 Roche Neurological Biomarkers Product Offered

12.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Roche Main Business Overview

12.5.5 Roche Latest Developments

12.6 Illumina

12.6.1 Illumina Company Information

12.6.2 Illumina Neurological Biomarkers Product Offered

12.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Illumina Main Business Overview

12.6.5 Illumina Latest Developments

12.7 Bio-Rad Laboratories

12.7.1 Bio-Rad Laboratories Company Information

12.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Offered

12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Bio-Rad Laboratories Main Business Overview

12.7.5 Bio-Rad Laboratories Latest Developments

12.8 QIAGEN

12.8.1 QIAGEN Company Information

12.8.2 QIAGEN Neurological Biomarkers Product Offered

12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 QIAGEN Main Business Overview

12.8.5 QIAGEN Latest Developments

12.9 Myriad RBM

12.9.1 Myriad RBM Company Information

12.9.2 Myriad RBM Neurological Biomarkers Product Offered

12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Myriad RBM Main Business Overview

12.9.5 Myriad RBM Latest Developments

12.10 Cisbio Bioassays

12.10.1 Cisbio Bioassays Company Information

12.10.2 Cisbio Bioassays Neurological Biomarkers Product Offered

12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Cisbio Bioassays Main Business Overview

12.10.5 Cisbio Bioassays Latest Developments

12.11 Athena Diagnostics

12.11.1 Athena Diagnostics Company Information

12.11.2 Athena Diagnostics Neurological Biomarkers Product Offered

12.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Athena Diagnostics Main Business Overview

12.11.5 Athena Diagnostics Latest Developments

12.12 BGI

12.12.1 BGI Company Information

12.12.2 BGI Neurological Biomarkers Product Offered

12.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 BGI Main Business Overview

12.12.5 BGI Latest Developments

12.13 Wuxi APP

12.13.1 Wuxi APP Company Information

12.13.2 Wuxi APP Neurological Biomarkers Product Offered

12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Wuxi APP Main Business Overview

12.13.5 Wuxi APP Latest Developments

12.14 Aepodia

12.14.1 Aepodia Company Information

12.14.2 Aepodia Neurological Biomarkers Product Offered

12.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Aepodia Main Business Overview

12.14.5 Aepodia Latest Developments

12.15 Proteome Sciences

12.15.1 Proteome Sciences Company Information

12.15.2 Proteome Sciences Neurological Biomarkers Product Offered

12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Proteome Sciences Main Business Overview

12.15.5 Proteome Sciences Latest Developments

12.16 Genewiz

12.16.1 Genewiz Company Information

12.16.2 Genewiz Neurological Biomarkers Product Offered

12.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Genewiz Main Business Overview

12.16.5 Genewiz Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Neurological Biomarkers Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Proteomics

Table 3. Major Players of Genomics

Table 4. Major Players of Imaging

Table 5. Major Players of Bioinformatics

Table 6. Major Players of Others

Table 7. Global Neurological Biomarkers Sales by Type (2016-2021) & (K Units)

Table 8. Global Neurological Biomarkers Sales Market Share by Type (2016-2021)

Table 9. Global Neurological Biomarkers Revenue by Type (2016-2021) & ($ million)

Table 10. Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)

Table 11. Global Neurological Biomarkers Sale Price by Type (2016-2021)

Table 12. Global Neurological Biomarkers Sales by Application (2016-2021) & (K Units)

Table 13. Global Neurological Biomarkers Sales Market Share by Application (2016-2021)

Table 14. Global Neurological Biomarkers Value by Application (2016-2021)

Table 15. Global Neurological Biomarkers Revenue Market Share by Application (2016-2021)

Table 16. Global Neurological Biomarkers Sale Price by Application (2016-2021)

Table 17. Global Neurological Biomarkers Sales by Company (2019-2021) & (K Units)

Table 18. Global Neurological Biomarkers Sales Market Share by Company (2019-2021)

Table 19. Global Neurological Biomarkers Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Neurological Biomarkers Revenue Market Share by Company (2019-2021)

Table 21. Global Neurological Biomarkers Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Neurological Biomarkers Producing Area Distribution and Sales Area

Table 23. Players Neurological Biomarkers Products Offered

Table 24. Neurological Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Neurological Biomarkers Sales by Region (2016-2021) (K Units)

Table 28. Global Neurological Biomarkers Sales Market Share by Region (2016-2021)

Table 29. Global Neurological Biomarkers Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)

Table 31. Americas Neurological Biomarkers Sales by Country (2016-2021) & (K Units)

Table 32. Americas Neurological Biomarkers Sales Market Share by Country (2016-2021)

Table 33. Americas Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Neurological Biomarkers Revenue Market Share by Country (2016-2021)

Table 35. Americas Neurological Biomarkers Sales by Type (2016-2021) & (K Units)

Table 36. Americas Neurological Biomarkers Sales Market Share by Type (2016-2021)

Table 37. Americas Neurological Biomarkers Sales by Application (2016-2021) & (K Units)

Table 38. Americas Neurological Biomarkers Sales Market Share by Application (2016-2021)

Table 39. APAC Neurological Biomarkers Sales by Region (2016-2021) & (K Units)

Table 40. APAC Neurological Biomarkers Sales Market Share by Region (2016-2021)

Table 41. APAC Neurological Biomarkers Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Neurological Biomarkers Revenue Market Share by Region (2016-2021)

Table 43. APAC Neurological Biomarkers Sales by Type (2016-2021) & (K Units)

Table 44. APAC Neurological Biomarkers Sales Market Share by Type (2016-2021)

Table 45. APAC Neurological Biomarkers Sales by Application (2016-2021) & (K Units)

Table 46. APAC Neurological Biomarkers Sales Market Share by Application (2016-2021)

Table 47. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units)

Table 48. Europe Neurological Biomarkers Sales Market Share by Country (2016-2021)

Table 49. Europe Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Neurological Biomarkers Revenue Market Share by Country (2016-2021)

Table 51. Europe Neurological Biomarkers Sales by Type (2016-2021) & (K Units)

Table 52. Europe Neurological Biomarkers Sales Market Share by Type (2016-2021)

Table 53. Europe Neurological Biomarkers Sales by Application (2016-2021) & (K Units)

Table 54. Europe Neurological Biomarkers Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Neurological Biomarkers Sales by Country (2016-2021) & (K Units)

Table 56. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Neurological Biomarkers Sales by Type (2016-2021) & (K Units)

Table 60. Middle East & Africa Neurological Biomarkers Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Neurological Biomarkers Sales by Application (2016-2021) & (K Units)

Table 62. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2016-2021)

Table 63. Global Neurological Biomarkers Sales Forecast by Type (2021-2026) & (K Units)

Table 64. Global Neurological Biomarkers Sales Market Share Forecast by Type (2021-2026)

Table 65. Global Neurological Biomarkers Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 66. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2021-2026)

Table 67. Global Neurological Biomarkers Sales Forecast by Application (2021-2026) & (K Units)

Table 68. Global Neurological Biomarkers Sales Market Share Forecast by Application (2021-2026)

Table 69. Global Neurological Biomarkers Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 70. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2021-2026)

Table 71. Thermo Fisher Scientific Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 72. Thermo Fisher Scientific Neurological Biomarkers Product Offered

Table 73. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 74. Thermo Fisher Scientific Main Business

Table 75. Thermo Fisher Scientific Latest Developments

Table 76. Merck Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 77. Merck Neurological Biomarkers Product Offered

Table 78. Merck Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 79. Merck Main Business

Table 80. Merck Latest Developments

Table 81. Quest Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 82. Quest Diagnostics Neurological Biomarkers Product Offered

Table 83. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 84. Quest Diagnostics Main Business

Table 85. Quest Diagnostics Latest Developments

Table 86. Abbott Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 87. Abbott Neurological Biomarkers Product Offered

Table 88. Abbott Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 89. Abbott Main Business

Table 90. Abbott Latest Developments

Table 91. Roche Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 92. Roche Neurological Biomarkers Product Offered

Table 93. Roche Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 94. Roche Main Business

Table 95. Roche Latest Developments

Table 96. Illumina Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 97. Illumina Neurological Biomarkers Product Offered

Table 98. Illumina Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 99. Illumina Main Business

Table 100. Illumina Latest Developments

Table 101. Bio-Rad Laboratories Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 102. Bio-Rad Laboratories Neurological Biomarkers Product Offered

Table 103. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 104. Bio-Rad Laboratories Main Business

Table 105. Bio-Rad Laboratories Latest Developments

Table 106. QIAGEN Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 107. QIAGEN Neurological Biomarkers Product Offered

Table 108. QIAGEN Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 109. QIAGEN Main Business

Table 110. QIAGEN Latest Developments

Table 111. Myriad RBM Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 112. Myriad RBM Neurological Biomarkers Product Offered

Table 113. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 114. Myriad RBM Main Business

Table 115. Myriad RBM Latest Developments

Table 116. Cisbio Bioassays Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 117. Cisbio Bioassays Neurological Biomarkers Product Offered

Table 118. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 119. Cisbio Bioassays Main Business

Table 120. Cisbio Bioassays Latest Developments

Table 121. Athena Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 122. Athena Diagnostics Neurological Biomarkers Product Offered

Table 123. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 124. Athena Diagnostics Main Business

Table 125. Athena Diagnostics Latest Developments

Table 126. BGI Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 127. BGI Neurological Biomarkers Product Offered

Table 128. BGI Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 129. BGI Main Business

Table 130. BGI Latest Developments

Table 131. Wuxi APP Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 132. Wuxi APP Neurological Biomarkers Product Offered

Table 133. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 134. Wuxi APP Main Business

Table 135. Wuxi APP Latest Developments

Table 136. Aepodia Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 137. Aepodia Neurological Biomarkers Product Offered

Table 138. Aepodia Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 139. Aepodia Main Business

Table 140. Aepodia Latest Developments

Table 141. Proteome Sciences Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 142. Proteome Sciences Neurological Biomarkers Product Offered

Table 143. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 144. Proteome Sciences Main Business

Table 145. Proteome Sciences Latest Developments

Table 146. Genewiz Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 147. Genewiz Neurological Biomarkers Product Offered

Table 148. Genewiz Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 149. Genewiz Main Business

Table 150. Genewiz Latest Developments

List of Figures

Figure 1. Picture of Neurological Biomarkers

Figure 2. Neurological Biomarkers Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neurological Biomarkers Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Neurological Biomarkers Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Neurological Biomarkers Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Proteomics

Figure 10. Product Picture of Genomics

Figure 11. Product Picture of Imaging

Figure 12. Product Picture of Bioinformatics

Figure 13. Product Picture of Others

Figure 14. Global Neurological Biomarkers Sales Market Share by Type in 2020

Figure 15. Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)

Figure 16. Neurological Biomarkers Consumed in Diagnostics

Figure 17. Global Neurological Biomarkers Market: Diagnostics (2016-2021) & (K Units)

Figure 18. Neurological Biomarkers Consumed in Drug Discovery

Figure 19. Global Neurological Biomarkers Market: Drug Discovery (2016-2021) & (K Units)

Figure 20. Neurological Biomarkers Consumed in Personalized Medicine

Figure 21. Global Neurological Biomarkers Market: Personalized Medicine (2016-2021) & (K Units)

Figure 22. Neurological Biomarkers Consumed in Others

Figure 23. Global Neurological Biomarkers Market: Others (2016-2021) & (K Units)

Figure 24. Global Neurological Biomarkers Sales Market Share by Application (2016-2021)

Figure 25. Global Neurological Biomarkers Revenue Market Share by Application in 2020

Figure 26. Global Neurological Biomarkers Revenue Market by Company in 2020 ($ Million)

Figure 27. Global Neurological Biomarkers Revenue Market Share by Company in 2020

Figure 28. Global Neurological Biomarkers Sales Market Share by Regions (2016-2021)

Figure 29. Global Neurological Biomarkers Revenue Market Share by Region in 2020

Figure 30. Americas Neurological Biomarkers Sales 2016-2021 (K Units)

Figure 31. Americas Neurological Biomarkers Revenue 2016-2021 ($ Millions)

Figure 32. APAC Neurological Biomarkers Sales 2016-2021 (K Units)

Figure 33. APAC Neurological Biomarkers Revenue 2016-2021 ($ Millions)

Figure 34. Europe Neurological Biomarkers Sales 2016-2021 (K Units)

Figure 35. Europe Neurological Biomarkers Revenue 2016-2021 ($ Millions)

Figure 36. Middle East & Africa Neurological Biomarkers Sales 2016-2021 (K Units)

Figure 37. Middle East & Africa Neurological Biomarkers Revenue 2016-2021 ($ Millions)

Figure 38. Americas Neurological Biomarkers Sales Market Share by Country in 2020

Figure 39. Americas Neurological Biomarkers Revenue Market Share by Country in 2020

Figure 40. Americas Neurological Biomarkers Sales Market Share by Type in 2020

Figure 41. Americas Neurological Biomarkers Sales Market Share by Application in 2020

Figure 42. United States Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 43. Canada Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 44. Mexico Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 45. Brazil Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 46. APAC Neurological Biomarkers Sales Market Share by Region in 2020

Figure 47. APAC Neurological Biomarkers Revenue Market Share by Regions in 2020

Figure 48. APAC Neurological Biomarkers Sales Market Share by Type in 2020

Figure 49. APAC Neurological Biomarkers Sales Market Share by Application in 2020

Figure 50. China Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 51. Japan Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 52. Korea Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 53. Southeast Asia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 54. India Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 55. Australia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 56. Europe Neurological Biomarkers Sales Market Share by Country in 2020

Figure 57. Europe Neurological Biomarkers Revenue Market Share by Country in 2020

Figure 58. Europe Neurological Biomarkers Sales Market Share by Type in 2020

Figure 59. Europe Neurological Biomarkers Sales Market Share by Application in 2020

Figure 60. Germany Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 61. France Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 62. UK Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 63. Italy Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 64. Russia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 65. Middle East & Africa Neurological Biomarkers Sales Market Share by Country in 2020

Figure 66. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country in 2020

Figure 67. Middle East & Africa Neurological Biomarkers Sales Market Share by Type in 2020

Figure 68. Middle East & Africa Neurological Biomarkers Sales Market Share by Application in 2020

Figure 69. Egypt Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 70. South Africa Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 71. Israel Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 72. Turkey Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 73. GCC Country Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions)

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles